Stock Earnings

Question 1

Shanghai Pharmaceuticals Holding Co Ltd'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Shanghai Pharmaceuticals Holding Co Ltd'in toplam varlıkları $221,209 olup, net profit $4,552'dir.

Question 2

SHPMF'ün temel finansal oranları nelerdir?

Accepted Answer

Shanghai Pharmaceuticals Holding Co Ltd'in cari oranı 1.47, net kâr marjı 1.65, hisse başına satış $74.31'dir.

Question 3

Shanghai Pharmaceuticals Holding Co Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Currently Shanghai Pharmaceuticals Holding Co Ltd data is not available.

Question 4

Shanghai Pharmaceuticals Holding Co Ltd kârlı mı?

Accepted Answer

yes, son mali tablolara göre Shanghai Pharmaceuticals Holding Co Ltd'in net profit $4,552'dir.

Question 5

Shanghai Pharmaceuticals Holding Co Ltd'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Shanghai Pharmaceuticals Holding Co Ltd'in yükümlülüğü 149,533'dir.

Question 6

Shanghai Pharmaceuticals Holding Co Ltd'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Shanghai Pharmaceuticals Holding Co Ltd'in toplam tedavüldeki hisse sayısı 3,707.97'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	280,694	275,250	260,295	231,981	215,824	191,909
Revenue Growth (YoY)	3%	6%	12%	7%	12%	3%
Cost of Revenue	251,639	244,758	229,276	201,503	187,332	164,871
Gross Profit	29,055	30,492	31,018	30,477	28,491	27,039
Selling, General & Admin	18,688	17,932	19,279	18,914	17,751	16,696
Research & Development	2,293	2,162	1,998	1,940	1,827	1,540
Operating Expenses	21,584	21,255	22,157	22,162	20,690	19,299
Other Non Operating Income (Expenses)	-134	-94	-600	-168	-53	26
Pretax Income	9,673	8,020	7,054	8,808	8,143	7,175
Income Tax Expense	2,840	2,149	1,887	1,816	1,869	1,570
Net Income	5,645	4,552	3,767	5,617	5,093	4,496
Net Income Growth	40%	21%	-33%	10%	13%	10%
Shares Outstanding (Diluted)	3,677.33	3,704.06	3,701.29	3,482.73	2,845.51	2,846
Shares Change (YoY)	-1%	0%	6%	22%	0%	0%
EPS (Diluted)	1.52	1.22	1.01	1.61	1.79	1.58
EPS Growth	40%	21%	-37%	-10%	13%	10%
Free Cash Flow	3,216	3,426	2,260	2,058	942	3,834
Free Cash Flow Per Share	0.87	0.92	0.61	0.59	0.33	1.34
Gross Margin	10.35%	11.07%	11.91%	13.13%	13.2%	14.08%
Operating Margin	2.66%	3.35%	3.4%	3.58%	3.61%	4.03%
Profit Margin	2.01%	1.65%	1.44%	2.42%	2.35%	2.34%
Free Cash Flow Margin	1.14%	1.24%	0.86%	0.88%	0.43%	1.99%
EBITDA	--	10,944	10,417	9,872	9,334	9,311
EBITDA Margin	--	3.97%	4%	4.25%	4.32%	4.85%
D&A For EBITDA	--	1,707	1,557	1,557	1,534	1,571
EBIT	7,471	9,237	8,860	8,315	7,800	7,740
EBIT Margin	2.66%	3.35%	3.4%	3.58%	3.61%	4.03%
Effective Tax Rate	29.36%	26.79%	26.75%	20.61%	22.95%	21.88%

Shanghai Pharmaceuticals Holding Co Ltd (SHPMF) Price